In vivo metabolism of substance P in rat striatum utilizing microdialysis/liquid chromatography/micro-electrospray mass spectrometry
✍ Scribed by Per E. André; Richard M. Caprioli
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 757 KB
- Volume
- 30
- Category
- Article
- ISSN
- 1076-5174
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
In vivo microdialysis in combination with liquid chromatography/micro‐electrospray mass spectrometry was used to study the metabolism of substance P in rat brain. A microdialysis probe was used both to introduce substance P into the brain and to collect metabolic products. Unilateral infusions of 25 and 50 pmol μl^−1^ substance P, or isotopically labeled [D~8~‐Phe^8^] substance P, at flow rates of 0.3 μl min^−1^, were made through the microdialysis probe implanted in the striatum of anesthetized rats. The metabolic products were analyzed by on‐line mass spectrometry and the results showed that substance P, an 11 amino acid residue polypeptide, was metabolized in the striatum to form N‐terminal fragments 1–9, 1–8 and 1–7; C‐terminal fragments 3–11, 5–11, 6–11, 7–11 and 8–11; and internal fragments 4–8, 6–10 and 7–10. The concentrations of these metabolites in dialysates were measured in order to compare the relative importance of several possible metabolic degradative pathways.
📜 SIMILAR VOLUMES
Liquid chromatography/tandem mass spectrometry (LC/MS/MS) has been coupled to in vivo microdialysis for on-line monitoring of melatonin in a freely moving rat for a period of 15 hours. A microdialysis probe was surgically implanted into the jugular vein of the rat, and deionized water was used as th
## Abstract Sinomenine (7,8‐didehydro‐4‐hydroxy‐3,7‐dimethoxy‐17‐methylmorphinan‐6‐one) is a pure alkaloid extracted from the Chinese medical plant. In this report a liquid chromatography–electrospray mass spectrometry (LC–ESI‐MS) method with __in vivo__ microdialysis for the pharmacokinetic study
## Abstract KR‐31831 ((2__S__,3__R__,4__S__)‐4‐(((1H‐imidazol‐2‐yl)methyl)(4‐chlorophenyl)amino)‐6‐amino‐2‐(dimethoxymethyl)‐2‐methyl‐3,4‐dihydro‐2H‐chromen‐3‐ol) is a novel antiangiogenic agent. __In vitro__ and __in vivo__ metabolism of KR‐31831 in rats has been investigated using LC‐MS and LC‐MS